Toxic corneal ulcer: A frequent and sight-threatening disease

European Journal of Ophthalmology

Volumn 19, Issue 6, 2009, Pages 916-922

  Sacchetti, Marta ^a   Lambiase, Alessandro ^a   Coassin, Marco ^a   Bonini, Sergio ^b   Bonini, Stefano ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Cornea; Corneal ulcer; Drug toxicity; Latrogenic diseases

Indexed keywords

ANTIBIOTIC AGENT; ANTIGLAUCOMA AGENT; ANTIVIRUS AGENT; ARTIFICIAL TEAR; CYCLOPLEGIC AGENT; LUBRICATING AGENT; MYDRIATIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID; EYE DROPS;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORNEA ULCER; DISEASE DURATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG SAFETY; DRUG USE; FEMALE; HEALING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SCAR FORMATION; TOPICAL TREATMENT; TREATMENT DURATION; VISUAL ACUITY; VISUAL IMPAIRMENT; CHEMICALLY INDUCED DISORDER; CORNEA; DRUG EFFECT; DRUG HYPERSENSITIVITY; IATROGENIC DISEASE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDY; VISUAL DISORDER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CORNEA; CORNEAL ULCER; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; IATROGENIC DISEASE; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; VISION DISORDERS; VISUAL ACUITY; YOUNG ADULT;

EID: 73949138477     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210901900604     Document Type: Article

References (23)

1. Wilson FM II. Adverse external ocular effects of topical ophthalmic medications. Surv Ophthalmol 1979; 24: 57-88.
2. Fraunfelder FW. Corneal toxicity from topical ocular and systemic medications. Cornea 2006; 25: 1133-8.
3. Bernauer W. Ocular surface problems following topical medication. Klin Monatsbl Augenheilkd 2002; 219: 240-2.
4. Schwab IR, Abbott RL. Toxic ulcerative keratopathy. An unrecognized problem. Ophthalmology 1989; 96: 1187-93.
5. Furrer P, Mayer JM, Gurny R. Ocular tolerance of preservatives and alternatives. Eur J Pharm Biopharm 2002; 53: 263-80.
6. Burstein NL. Corneal cytotoxicity of topically applied drugs, vehicles and preservatives. Surv Ophthalmol 1980; 25: 15-30.
7. Wilson FM II. Adverse external ocular effects of topical ophthalmic therapy: an epidemiologic, laboratory, and clinical study. Trans Am Ophthalmol Soc 1983; 81: 854-965.
8. Baudouin C. Allergic reaction to topical eyedrops. Curr Opin Allergy Clin Immunol 2005; 5: 459-63.
9. Dart J. Corneal toxicity: the epithelium and stroma in iatrogenic and factitious disease. Eye 2003; 17: 886-92.
10. DeRosa AJ. Toxic keratopathy. Int Ophthalmol Clin 1998; 38: 15-22.
11. Tuli SS, Schultz GS, Downer DM. Science and strategy for preventing and managing corneal ulceration. Ocul Surf 2007; 5: 23-39.
12. Dahlgren MA, Lingappan A, Wilhelmus KR. The clinical diagnosis of microbial keratitis. Am J Ophthalmol 2007; 143: 940-4.
13. Fantes FE, Hanna KD, Waring GO III, Pouliquen Y, Thompson KP, Savoldelli M. Wound healing after excimer laser keratomileusis (photorefractive keratectomy) in monkeys. Arch Ophthalmol 1990; 108: 665-75.
14. Rochon PA, Gurwitz JH. Drug therapy. Lancet 1995; 346: 32-6.
15. Duke-Elder S. The clinical value of cortisone and ACTH in ocular disease. A preliminary assessment for the Medical Research Council. Br J Ophthalmol 1951; 35: 637-71.
16. Wilhelmus KR. Indecision about corticosteroids for bacterial keratitis. An evidence-based update. Ophthalmology. 2002; 109: 835-42.
17. Dua HS, Gomes JA, Singh A. Corneal epithelial wound healing. Br J Ophthalmol 1994; 78: 401-8.
18. Lu KL, Wee WR, Sakamoto T, McDonnell PJ. Comparison of in vitro antiproliferative effects of steroids and nonsteroidal antiinflammatory drugs on human keratocytes. Cornea 1996; 15: 185-90.
19. Acosta MC, Berenguer-Ruiz L, García-Gálvez A, et al. Changes in mechanical, chemical, and thermal sensitivity of the cornea after topical application of nonsteroidal anti-inflammatory drugs. Invest Ophthalmol Vis Sci 2005; 46: 282-6.
20. O'Brien TP, Li QJ, Sauerburger F, Reviglio VE, Rana T, Ashraf MF. The role of matrix metalloproteinases in ulcerative keratolysis associated with perioperative diclofenac use. Ophthalmology 2001; 108: 656-9.
21. Baudouin C. Side effects of antiglaucomatous drugs on the ocular surface. Curr Opin Ophthalmol 1996; 7: 80-6.
22. Flach AJ. Corneal melts associated with topically applied nonsteroidal anti-inflammatory drugs. Trans Am Ophthalmol Soc 2001; 99: 205-10.
23. Guidera AC, Luchs JI, Udell IJ. Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs. Ophthalmology 2001; 108: 936-44.